13F Holdings
中文EN

Pivotal bioVenture Partners Investment Advisor LLC

SAN FRANCISCO CA · SEC CIK 0001844645

2026Q22026Q1 9 earlier quarters 🔒
$307.79M2026Q2 reported value
13Positions
95.1%Top 10 weight · largest 26.9%
0 / 1New / sold out
Reported value over time$307.79M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

PCVX 26.9%
ARQT 10.8%
TRVI 10.6%
AVLN 10.3%
EVMN 8.3%
MPLT 7.1%
OCS 6.8%
BIOA 5.2%
IMNM 5.0%
ZBIO 4.0%

2026Q2 top buys estimated at quarter-end value

TRVI Added+$3.52M
PCVX Added+$3.08M
AVTX Added+$2.55M

2026Q2 top sells estimated at quarter-end value

ZBIO Reduced-$2.57M
OCS Reduced-$2.41M
ARQT Reduced-$2.38M
BOLT BIOTHERAPEU Sold out-$172,027
MPLT Reduced-$36

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
PCVX VAXCYTE INC $82.86M26.92%1,425,470 53,0453.9% $3.08M Added
ARQT ARCUTIS BIOTHERAPEUTICS INC $33.18M10.78%1,265,283 -90,609-6.7% -$2.38M Reduced
TRVI TREVI THERAPEUTICS INC $32.50M10.56%1,742,672 188,94612.2% $3.52M Added
AVLN AVALYN PHARMACEUTICALS INC $31.83M10.34%966,792 966,792— — First reported
EVMN EVOMMUNE INC $25.61M8.32%1,926,943 00.0% — Unchanged
MPLT MAPLIGHT THERAPEUTICS INC $21.91M7.12%611,446 -1-0.0% -$36 Reduced
OCS OCULIS HOLDING AG $20.89M6.79%1,506,250 -174,033-10.4% -$2.41M Reduced
BIOA BIOAGE LABS INC $16.01M5.20%653,374 00.0% — Unchanged
IMNM IMMUNOME INC $15.52M5.04%732,512 00.0% — Unchanged
ZBIO ZENAS BIOPHARMA INC $12.46M4.05%490,766 -101,225-17.1% -$2.57M Reduced
AVTX AVALO THERAPEUTICS INC $8.02M2.61%434,033 138,10046.7% $2.55M Added
RLYB RALLYBIO CORP $4.81M1.56%300,579 00.0% — Unchanged
RXRX RECURSION PHARMACEUTICALS IN $2.19M0.71%595,518 00.0% — Unchanged
— BOLT BIOTHERAPEUTICS INC $00.00%0 -42,581-100.0% -$172,027 Sold out